Avricore Health (AVCRF) Shares Outstanding (Weighted Average) (2013 - 2025)

Avricore Health (AVCRF) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $19.6 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $19.6 million, changed 0.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.6 million (changed 0.17% YoY), and the FY2025 annual result was $19.5 million, down 2.01% from the prior year.
• Shares Outstanding (Weighted Average) declined to $19.6 million in Q4 2025 per AVCRF's latest filing, from $19.8 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $77.4 million in Q4 2021 and troughed at $19.0 million in Q1 2025.
• A 5-year average of $60.5 million and a median of $73.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Weighted Average) soared 82.61% in 2021, then plunged 74.29% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $77.4 million in 2021, then decreased by 6.83% to $72.1 million in 2022, then advanced by 1.44% to $73.1 million in 2023, then slumped by 73.27% to $19.5 million in 2024, then increased by 0.17% to $19.6 million in 2025.
• Business Quant data shows AVCRF's Shares Outstanding (Weighted Average) at $19.6 million in Q4 2025, $19.8 million in Q3 2025, and $19.7 million in Q2 2025.